Abstract:Predicting antidepressant treatment response has been a clinical challenge for major depressive disorder (MDD). The inflammation hypothesis of depression suggests that cytokines play a key role in the pathophysiology of MDD and alterations in peripheral cytokine levels are associated with antidepressant treatment outcome. Present meta-analysis aimed to examine the association between baseline peripheral cytokine levels and the response to antidepressant treatment and to evaluate whether changes of cytokine levels were associated with the response to antidepressant treatment in patients with MDD. Human-based studies published in any language in peer-reviewed journals were systematically searched from the PubMed, Embase and Web of Science databases, from inception up to October 2018. The search terms included cytokine, depressive disorder and antidepressant and their synonyms. Case-control or case-case studies reporting on levels of IL-1 beta, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, CRP, TNF-alpha, IFN-gamma, GM-CSF, MIP-1 alpha, and Eotaxin-1 in patients with MDD based on validated depression scales both before and after antidepressant treatment were included. Of 7408 identified records, 44 studies met inclusion. Standardized mean differences in each cytokine were evaluated, and random-effects meta-analyses were performed. MDD patients who responded to antidepressant treatment had lower baseline IL-8 levels than the nonresponders (Hedge's g = -0.28; 95%CI, -0.43 to -0.13; P = 0.0003; FDR = 0.004). Antidepressant treatment significantly decreased levels of TNF-alpha (Hedge's g = 0.60; 95%CI, 0.26-0.94; P = 0.0006; FDR = 0.004) only in responders, and responders showed significantly more decreased TNF-alpha levels compared with nonresponders (P = 0.046). These findings suggested that alterations in peripheral cytokine levels were associated with antidepressant treatment outcomes in MDD. Further investigations are warranted to elucidate sources of heterogeneity and examine the potentiality of using inflammatory cytokines as novel predictive markers for the pharmacological treatment of MDD.

Expression changes of microRNA-132 in the peripheral blood mononuclear cells in patients with major depressive disorder before and after treatment

Alterations of Microrna-124 Expression in Peripheral Blood Mononuclear Cells in Pre- and Post-Treatment Patients with Major Depressive Disorder.

Increased Mir-132 Level is Associated with Visual Memory Dysfunction in Patients with Depression

Changes in Mirna-132 and Mir-124 Levels in Non-Treated and Citalopram-Treated Patients with Depression

Blood Mir-144-3p: a Novel Diagnostic and Therapeutic Tool for Depression

Changes in the level of micro RNA-206 gene expression in patients with type I bipolar disorder before and after treatment and comparison with a control population

The role of circulating blood microRNA-374 and microRNA-10 levels in the pathogenesis and therapeutic mechanisms of major depressive disorder

MicroRNA132 associated multimodal neuroimaging patterns in unmedicated major depressive disorder.

Peripheral Blood Mononuclear Cell Biomarkers for Major Depressive Disorder: A Transcriptomic Approach

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

Relaitonship of mean platelet volume to MDD: a retrospecitve study

Abnormal Expression Profile of Plasma-Derived Exosomal Micrornas in Patients with Treatment-Resistant Depression

Fluoxetine Treatment for Major Depression Decreases the Plasma Levels of Cytokines

Increased Expression of a Novel Mirna in Peripheral Blood is Negatively Correlated with Hippocampal Volume in Patients with Major Depressive Disorder.

The changes of serum interleukin-6 and level of brain derived neurotrophic factor in depression patients before and after treatment and its corresponding clinical significance

The study on the effects of antidepressants treatment on the mRNA expression of B-cell lymphoma Leukemia-2 in peripheral leucodyte from patients with treatment-resistant depression

Identifying the differentially expressed peripheral blood microRNAs in psychiatric disorders: a systematic review and meta-analysis

Down-regulated miR-16-2 in peripheral blood is positively correlated with decreased bilateral insula volume in patients with major depressive disorder

The Plasma IL-18, MIP-1α, MCP-1, SDF-1 and Rantes in Patients with Majior Depression

The alterations in CD4+Treg cells across various phases of major depression

Peripheral Cytokine Levels and Response to Antidepressant Treatment in Depression: a Systematic Review and Meta-Analysis